Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
reports
Sonnet BioTherapeutics Holdings (SONN) Stock Price & Analysis
341 Followers
SONN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.21 - $4.55
Previous Close$0.5
Volume3.91M
Average Volume (3M)2.95M
Market Cap
$10.16M
Enterprise Value-$999.40K
Total Cash (Recent Filing)$11.40M
Total Debt (Recent Filing)$237.61K
Price to Earnings (P/E)-0.1
Beta1.16
Next Earnings
May 10, 2023EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.62
Shares Outstanding27,478,686
10 Day Avg. Volume9,811,872
30 Day Avg. Volume2,952,031
Standard Deviation0.29
R-Squared0.00566
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)38.16
Price to Sales (P/S)378.72
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.03
Enterprise Value/Gross Profit-2.86
Enterprise Value/Ebitda0.07
Forecast
1Y Price Target
$10.35Price Target Upside1960.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Sonnet BioTherapeutics Holdings News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SONN FAQ
What was Sonnet BioTherapeutics Holdings’s price range in the past 12 months?
Sonnet BioTherapeutics Holdings lowest stock price was $0.20 and its highest was $4.55 in the past 12 months.
What is Sonnet BioTherapeutics Holdings’s market cap?
Currently, no data Available
When is Sonnet BioTherapeutics Holdings’s upcoming earnings report date?
Sonnet BioTherapeutics Holdings’s upcoming earnings report date is May 10, 2023 which is 25 days ago.
How were Sonnet BioTherapeutics Holdings’s earnings last quarter?
Sonnet BioTherapeutics Holdings released its earnings results on Feb 13, 2023. The company reported -$0.8 earnings per share for the quarter, beating the consensus estimate of -$1.1 by $0.3.
Is Sonnet BioTherapeutics Holdings overvalued?
According to Wall Street analysts Sonnet BioTherapeutics Holdings’s price is currently Undervalued.
Does Sonnet BioTherapeutics Holdings pay dividends?
Sonnet BioTherapeutics Holdings does not currently pay dividends.
What is Sonnet BioTherapeutics Holdings’s EPS estimate?
Sonnet BioTherapeutics Holdings’s EPS estimate is -$0.5.
How many shares outstanding does Sonnet BioTherapeutics Holdings have?
Sonnet BioTherapeutics Holdings has 20,232,904 shares outstanding.
What happened to Sonnet BioTherapeutics Holdings’s price movement after its last earnings report?
Sonnet BioTherapeutics Holdings reported an EPS of -$0.8 in its last earnings report, beating expectations of -$1.1. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Sonnet BioTherapeutics Holdings?
Currently, no hedge funds are holding shares in SONN
---
Sonnet BioTherapeutics Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.35 (1960.52% Upside)
$10.35 (1960.52% Upside)
Insider Transactions
Bought Shares
Worth $133.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 13.0%
Last 30 Days ▲ 16.3%
Last 30 Days ▲ 16.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.43%
12-Months-Change
Fundamentals
Return on Equity
-381.55%
Trailing 12-Months
Asset Growth
-11.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics (NASDAQ:SONN) is a clinical-stage biotechnology company that is focused on the development of drugs for the treatment of cancer.
---
Top 5 ETFs holding SONN
iShares Core S&P Total U.S. Stock Market ETF
$1.02
Up to five ETFs with an Outperform Smart Score that hold SONN. The ETFs are listed according to market value of SONN within the ETF
---
---